Organic oxygen compounds
Number of EDCs: 33
Chemical nameChemical identifierLiterature identifier
AcetaldehydeDED000002PMID:22538484, PMID:6723515, PMID:7128453
PropionaldehydeDED000007PMID:4035593
EthanolDED000009PMID:21432428, PMID:21463340, PMID:2318350, PMID:37994192, PMID:611632
FormaldehydeDED000010PMID:12916763
MethanolDED000014PMID:12490131, PMID:9241670
EndosulfanDED000049PMID:15261991, PMID:15832825, PMID:22198180, PMID:28559116, PMID:33728745, PMID:34164426, PMID:35051067, PMID:3827596, PMID:39549571, PMID:8593856
Diethyl etherDED000050PMID:12458191
GlutaraldehydeDED000054PMID:21372440
RaloxifeneDED000078PMID:15012627, PMID:27395752
1,4-CyclohexanedimethanolDED000159PMID:26289545
Allyl alcoholDED000164PMID:11288928, PMID:17160105, PMID:18383315, PMID:22127959, PMID:4035593
Ethylene glycol monomethyl etherDED000167PMID:1288759, PMID:4065311, PMID:6499822
AcetonylacetoneDED000169PMID:1288759, PMID:25388508
Ethylene glycol monoethyl etherDED000171PMID:19643169
Ethylene glycol monobutyl etherDED000173PMID:12571679
t-Butyl methyl etherDED000233PMID:10746943, PMID:10966521, PMID:19344668, PMID:19595749, PMID:35131586
CarmelloseDED000272PMID:25731162
tert-Amyl methyl etherDED000353PMID:12759095
Hydroxycyclohexyl phenyl ketoneDED000366PMID:26692070, PMID:34522900
2-Methyl-4'-(methylthio)-2-morpholinopropiophenoneDED000396PMID:26692070, PMID:34522900
2-ButenalDED000449PMID:16442836
Alpha-EndosulfanDED000512PMID:7925178, PMID:8593856
LipopolysaccharideDED000533PMID:11268341, PMID:36774801, PMID:8182612, PMID:8821744
Endosulfan IIDED000535PMID:33433340, PMID:7925178
5-Caffeylquinic acidDED000770PMID:31283213
NeanthineDED000781PMID:11080347
NitroglycerinDED000818PMID:35648594
TcpobopDED000823PMID:34971590, PMID:38340598
ChloranilDED000853PMID:38555059
AzacytidineDED000858PMID:39330587
StreptozocinDED000891PMID:32737781, PMID:32810643
DithiothreitolDED000957PMID:36122607
TembotrioneDED001007PMID:39195635
DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.